Skip to main content
# Title Department Research Year
71 Phytochemical investigation, molecular docking studies and DFT calculations on the antidiabetic and cytotoxic activities of Gmelina philippensis CHAM. Department of Medicinal Chemistry 2022
72 Tailoring of novel azithromycin loaded zinc oxide nanoparticles for wound healing Department of Microbiology and Immunology 2022
73 Novel Azine Linked Hybrids of 2-indolinone and Thiazolodinone Scaffolds as CDK2 Inhibitors with Potential Anticancer Activity: In Silico Design, Synthesis, Biological, Molecular Dynamics and Binding Free Energy Studies Department of Medicinal Chemistry 2022
74 Discovery of new pyrimido [5, 4-c] quinolines as potential antiproliferative agents with multitarget actions: Rapid synthesis, docking, and ADME studies Department of Pharmaceutical Organic Chemistry 2022
75 New 1,3,4-Oxadiazole-Chalcone/Benzimidazole Hybrids as Potent Anti-proliferative Agents Department of Pharmaceutical Organic Chemistry 2022
76 Long term high fat diet induces metabolic disorders and aggravates behavioral disorders and cognitive deficits in MAPT P301L transgenic mice Department of Pharmacology 2022
77 New 1, 2, 4‐oxadiazole/pyrrolidine hybrids as topoisomerase IV and DNA gyrase inhibitors with promising antibacterial activity Department of Pharmaceutical Organic Chemistry 2022
78 Electrochemical sensing of copper-chelator D- penicillamine based on complexation with gold nanoparticles modified copper based-metal organic frameworks Department of Pharmaceutical Analytical Chemistry 2022
79 Discovery of new cyanopyridine/chalcone hybrids as dual inhibitors of EGFR/BRAFV600E with promising antiproliferative properties Department of Pharmaceutical Organic Chemistry 2022
80 Computational Analysis of SAM Analogs as Methyltransferase Inhibitors of nsp16/nsp10 complex from SARS-CoV-2. 2022